摘要
慢性间歇性低氧(chronic intermittent hypoxia,CIH)是阻塞性睡眠呼吸暂停综合征(obstructive sleep apnea syndrome,OSAS)的典型生理病理特征之一,是导致OSAS多器官系统损伤的关键起始因素。而Toll样受体4(Toll-like receptor 4,TLR4)作为一种高度保守的免疫受体,参与多种炎症反应及炎症级联反应。近年来,TLR4信号通路在CIH诱导炎症反应中的作用已经引起了越来越多的关注和研究,为OSAS的诊断及治疗提供了新靶点。该文从CIH、TLR4、TLR4基因沉默实验及拮抗剂等方面的最新研究进展进行综述。
Chronic intermittent hypoxia(CIH)is one of the typical physiological and pathological characteristics of obstructive sleep apnea syndrome(OSAS),and is a key initial factor leading to multi-organ system injury of OSAS.Toll-like receptor 4(TLR4),as a highly conserved immune receptor,participates in a variety of inflammatory responses and inflammatory cascades.In recent years,the role of TLR4 signaling pathway in CIH inducing inflammatory response has attracted more and more attention and research,providing new targets for the diagnosis and treatment of OSAS.In this paper,we review the recent advances in CIH,TLR4,TLR4 gene silencing technology and antagonists.
作者
李辛岚
王耶盈(综述)
李永霞(审校)
LI Xin-lan;WANG Ye-ying;LI Yong-xia(The Second Ward of the Department of Respiratory and Critical Medicine, the Second Affiliated Hospital of Kunming Medical University, Yunnan 650101, China)
出处
《中国临床新医学》
2020年第9期936-940,共5页
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金
云南省教育厅科学研究基金项目(编号:2017zzx198)。
关键词
慢性间歇性低氧
TOLL样受体4
炎症反应
基因沉默实验
Chronic intermittent hypoxia(CIH)
Toll-like receptor 4(TLR4)
Inflammatory response
Gene silencing experiment
